[go: up one dir, main page]

EE200200298A - Asendatud ftalotsüaniinid ja nende lähteühendid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja materjal - Google Patents

Asendatud ftalotsüaniinid ja nende lähteühendid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja materjal

Info

Publication number
EE200200298A
EE200200298A EEP200200298A EEP200200298A EE200200298A EE 200200298 A EE200200298 A EE 200200298A EE P200200298 A EEP200200298 A EE P200200298A EE P200200298 A EEP200200298 A EE P200200298A EE 200200298 A EE200200298 A EE 200200298A
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical composition
parent compounds
substituted phthalocyanines
phthalocyanines
Prior art date
Application number
EEP200200298A
Other languages
English (en)
Estonian (et)
Inventor
John Cook Michael
James Heeney Martin
Original Assignee
Gentian As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929064.5A external-priority patent/GB9929064D0/en
Priority claimed from GBGB0025817.8A external-priority patent/GB0025817D0/en
Application filed by Gentian As filed Critical Gentian As
Publication of EE200200298A publication Critical patent/EE200200298A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/045—Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C09B47/0673—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile having alkyl radicals linked directly to the Pc skeleton; having carbocyclic groups linked directly to the skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Mathematical Physics (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Theoretical Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200200298A 1999-12-08 2000-12-08 Asendatud ftalotsüaniinid ja nende lähteühendid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja materjal EE200200298A (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9929064.5A GB9929064D0 (en) 1999-12-08 1999-12-08 Substituted phthalocyanines and their precursors
GB0012348A GB0012348D0 (en) 1999-12-08 2000-05-22 Substituted phthalocyanines and their precursors
GBGB0025817.8A GB0025817D0 (en) 1999-12-08 2000-10-20 Substituted phthalocyanines and their precursors
PCT/GB2000/004708 WO2001042368A1 (en) 1999-12-08 2000-12-08 Substituted phthalocyanines and their precursors

Publications (1)

Publication Number Publication Date
EE200200298A true EE200200298A (et) 2003-08-15

Family

ID=27255732

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200298A EE200200298A (et) 1999-12-08 2000-12-08 Asendatud ftalotsüaniinid ja nende lähteühendid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja materjal

Country Status (10)

Country Link
EP (1) EP1238016A1 (xx)
JP (1) JP2003516421A (xx)
AU (1) AU2192201A (xx)
CA (1) CA2394891A1 (xx)
CZ (1) CZ20021974A3 (xx)
EE (1) EE200200298A (xx)
HU (1) HUP0301099A3 (xx)
NO (1) NO20022663L (xx)
PL (1) PL355851A1 (xx)
WO (1) WO2001042368A1 (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60204767T2 (de) * 2001-03-21 2006-05-18 L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A. Metallsubstituierte, nicht zentrosymmetrische phthalocyanin-analoga, deren herstellung und verwendung zur photodynamischen therapie, und als in-vivo-diagnostikum
EP1346971B1 (en) 2002-03-18 2010-01-20 Sumitomo Chemical Company, Limited Production method for biarylalanine
CN100415715C (zh) * 2003-02-11 2008-09-03 杜锡光 紫菜嗪环中具有六个异吲哚结构亚单元的超酞菁类化合物、合成方法及用途
MXPA05012165A (es) 2003-05-14 2006-05-19 Univ Sherbrooke Porfirazinas amfifilicas trisulfonadas para aplicaciones fotodinamicas en medicina.
JP4809657B2 (ja) * 2005-09-29 2011-11-09 富士フイルム株式会社 ナフタロシアニン色素およびその製造方法
JP4942351B2 (ja) * 2006-01-31 2012-05-30 独立行政法人科学技術振興機構 光線力学治療抗癌剤
JP5296355B2 (ja) * 2007-09-11 2013-09-25 株式会社日本触媒 アリール基含有フタロシアニン化合物、その製造方法、及び、配合物
US8168359B2 (en) * 2008-03-10 2012-05-01 Xerox Corporation Nanosized particles of phthalocyanine pigments
CZ303612B6 (cs) * 2010-08-19 2013-01-09 Výzkumný ústav organických syntéz a.s. Sloucenina pro fotodynamickou inaktivaci soucasne grampozitivních bakterií, gramnegativních bakterií a patogenních kvasinek, na bázi derivátu ftalocyaninu, a pouzití této slouceniny
JP2012167189A (ja) * 2011-02-14 2012-09-06 Aisin Seiki Co Ltd フタロシアニン誘導体、フタロシアニン誘導体の製造方法および色素増感型太陽電池
JP2013193956A (ja) * 2012-03-15 2013-09-30 Saitama Univ ｔｅｔｒａｋｉｓ−トリアルキルまたはフェニルシリルエチニル置換フタロシアニンおよびその製造方法
JP6278386B2 (ja) * 2013-11-06 2018-02-14 国立研究開発法人産業技術総合研究所 フタロシアニン化合物及び有機半導体材料
CN103864645B (zh) * 2013-12-30 2016-08-17 常州大学 一种二取代全氟烷基邻苯二甲腈化合物及其制备方法
CN104016995A (zh) * 2014-06-26 2014-09-03 常州大学 八取代全氟烷基钴酞菁化合物及其制备方法
JP6608187B2 (ja) * 2015-06-22 2019-11-20 山本化成株式会社 増感色素、半導体電極、光電変換素子および色素増感太陽電池
EP3287451B1 (de) 2016-08-24 2019-12-11 Cynora Gmbh Organische moleküle, insbesondere zur verwendung in organischen optoelektronischen vorrichtungen
CN108017650A (zh) * 2017-03-08 2018-05-11 先尼科化工（上海）有限公司 一种用于滤光片的酞菁化合物及其制备方法和应用方法
JP6922361B2 (ja) * 2017-04-07 2021-08-18 Jsr株式会社 固体撮像素子用組成物、赤外線遮蔽膜及び固体撮像素子
US11174274B2 (en) * 2017-04-07 2021-11-16 Yamamoto Chemicals, Inc. Naphthalocyanine compound, method for producing same, and use thereof
JP7128803B2 (ja) * 2017-04-07 2022-08-31 山本化成株式会社 フタロシアニン系化合物、及びその用途
WO2020071470A1 (ja) * 2018-10-05 2020-04-09 山本化成株式会社 フタロシアニン系化合物、及びその用途
CN112279856B (zh) * 2019-07-24 2021-09-17 南方科技大学 一种非外围取代的可溶性金属酞菁及其合成方法和应用、一种钙钛矿太阳能电池
CN112014383B (zh) * 2020-06-30 2024-03-29 杜旭忠 一种用于均相化学发光的光敏剂及其制备方法和应用
KR20230044432A (ko) * 2020-07-31 2023-04-04 스미또모 가가꾸 가부시키가이샤 화합물
CN112812299B (zh) * 2020-12-31 2022-03-29 四川大学 邻苯二甲腈与氨基酸环肽共聚树脂及其制备方法
WO2022196089A1 (ja) * 2021-03-15 2022-09-22 ソニーグループ株式会社 リポソーム複合体、物質送達システム、物質送達方法及び光照射装置
EP4574911A1 (en) 2023-12-22 2025-06-25 Holland Colours N. V. Bio-sourced phthalocyanine complex, preparation and use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE51402T1 (de) * 1984-03-21 1990-04-15 Ici Plc Infrarot-absorber.
GB8431446D0 (en) * 1984-12-13 1985-01-23 Secr Defence Alkoxyphthalocyanines
GB8619238D0 (en) * 1986-08-06 1986-09-17 Ici Plc Organic photoconductor
JP2613647B2 (ja) * 1987-02-13 1997-05-28 イギリス国 置換フタロシアニン
JPH0730300B2 (ja) * 1988-04-01 1995-04-05 三井東圧化学株式会社 アルキルフタロシアニン近赤外線吸収剤及びそれを用いた表示・記録材料
DE68928559T2 (de) * 1988-12-15 1998-06-18 Mitsui Toatsu Chemicals Absorbiermittel im nahen Infrarot und Anzeige-/Aufzeichnungsmaterialien, die daraus hergestellt sind
JPH07103093B2 (ja) * 1989-01-12 1995-11-08 三井東圧化学株式会社 フタロニトリル系化合物およびその製造方法
EP0519423B1 (en) * 1991-06-19 1999-03-03 Mitsui Chemicals, Inc. Phthalocyanine compounds and usage thereof
ES2127455T3 (es) * 1991-11-08 1999-04-16 Eastman Chem Co Composicion de polimero termoplastico que tiene mezclado con ella uno o mas compuestos monomericos fluorescentes en el infrarrojo proximo.
GB9317881D0 (en) * 1993-08-27 1993-10-13 Secr Defence Photosensitizers
US5456998A (en) * 1994-04-26 1995-10-10 Xerox Corporation Photoconductive imaging members containing alkoxy-bridged metallophthalocyanine dimers
JPH0892190A (ja) * 1994-09-26 1996-04-09 Kanto Chem Co Inc シアノビフェニル誘導体並びにそれらを含む液晶組成物
GB9613476D0 (en) * 1996-06-27 1996-08-28 British Polythene Ltd Improvements in or relating to films and/or coatings
IT1294325B1 (it) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
WO2000021965A1 (en) * 1998-10-13 2000-04-20 Brown University Research Foundation Substituted perhalogenated phthalocyanines

Also Published As

Publication number Publication date
PL355851A1 (en) 2004-05-31
CA2394891A1 (en) 2001-06-14
EP1238016A1 (en) 2002-09-11
JP2003516421A (ja) 2003-05-13
NO20022663D0 (no) 2002-06-05
NO20022663L (no) 2002-08-08
AU2192201A (en) 2001-06-18
HUP0301099A2 (hu) 2003-08-28
CZ20021974A3 (cs) 2002-11-13
HUP0301099A3 (en) 2003-11-28
WO2001042368A1 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
EE200200298A (et) Asendatud ftalotsüaniinid ja nende lähteühendid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja materjal
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
EE200200017A (et) Kinuklidiinderivaadid, nende valmistamismeetod, vaheühendid, farmatseutiline kompositsioon ja nendekasutamine
EE200100252A (et) Pürimidiinderivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja sellevalmistamismeetod, kombinatsioon ning saadus
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
EE05214B1 (et) Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
EE04399B1 (et) Spiroasabitsüklilised heterotsüklilised ühendid, nende valmistamise protsess, neid sisaldavad ravimkoostised ja nende kasutamine ravis
HUP0203183A3 (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
HUP0203136A3 (en) Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use
EE200000707A (et) Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0203548A3 (en) New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
EE200000596A (et) Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
NO20016038D0 (no) Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200000767A (et) Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
EE04346B1 (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
FI956278A0 (fi) Substituoituja 4-fenyylitiatsolijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
FI960316A7 (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät fa rmaseuttiset koostumukset
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
FI955085L (fi) Uudet diosmetiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset